USE OF A SIRNA FOR TREATING CANCER
The present invention concerns a composition comprising at least one siRNA, said siRNA hybridising with a coding or non-coding mRNA, in which it induces degradation or inhibits translation, the expression of said mRNA or of the protein for which it codes being implicated in a pathology, for the use...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
18.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention concerns a composition comprising at least one siRNA, said siRNA hybridising with a coding or non-coding mRNA, in which it induces degradation or inhibits translation, the expression of said mRNA or of the protein for which it codes being implicated in a pathology, for the use of same in the prevention and/or the treatment of said pathology, said composition being formulatedfor a continuous systemic administration mode, and a device comprising such an administration mode.
本发明涉及一种至少包括一种siRNA的组合物,所述siRNA与编码或非编码mRNA杂交以诱导所述mRNA降解或抑制所述mRNA的翻译,所述mRNA或其编码蛋白的表达参与疾病,所述组合物用于预防和/或治疗所述疾病,所述组合物被配制用于连续的全身给药模式,本发明还涉及包含这样给药模式的装置。 |
---|---|
Bibliography: | Application Number: CN201780081248 |